Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
70 studies found for:    Open Studies | "Antiretroviral Therapy, Highly Active" OR HAART

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Examining Benefits of HAART Continuation in Postpartum Mothers
Condition: HIV Infections
Intervention: Drug: Highly active antiretroviral therapy (HAART)
2 Unknown † HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users
Conditions: HIV;   Drug Use Disorders
Interventions: Behavioral: HEART to HAART;   Behavioral: adherence counseling with the addition of smartphone control
3 Unknown † Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Genetic: GX-12;   Drug: HAART
4 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
5 Recruiting Early Antiviral Therapy for Critically Ill HIV Infected Patients
Condition: HIV Infection
Interventions: Drug: early HAART;   Drug: Late HAART
6 Unknown † Efficacy of Neuro-HAART in Patients With HIV
Condition: HIV
Intervention:
7 Unknown † Heart Function in HIV-Negative Children Exposed to HIV and HAART
Condition: HIV Infections
Intervention:
8 Recruiting DRV/r + RPV QD: Efficacy and Toxicity Reduction
Condition: Human Immunodeficiency Virus
Interventions: Drug: RPV + DRV/r;   Drug: continue the PI/r-containing HAART.
9 Recruiting Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)
Conditions: Human Immunodeficiency Virus;   Immune Reconstitution Inflammatory Syndrome
Interventions: Other: Urgent ART;   Other: Early ART
10 Unknown † A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Maraviroc
11 Recruiting Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART)
Condition: HIV Infection
Intervention: Drug: Hydroxychloroquine
12 Recruiting Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
Conditions: Lymphoma-AIDS-Related;   Brain Neoplasm
Interventions: Drug: Methotrexate;   Drug: Rituximab;   Drug: Leucovorin
13 Unknown † Effects of a Phone Call Intervention to Promote HAART Adherence
Condition: Medication Adherence
Intervention: Behavioral: Phone call intervention, no phone call intervention
14 Recruiting A Study of Selumetinib in Patients With Kaposi's Sarcoma
Condition: AIDS-related Kaposi's Sarcoma
Intervention: Drug: Selumetinib
15 Unknown † Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda
Condition: HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: Placebo
16 Unknown † Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen
Conditions: HIV;   Hypercholesterolemia;   Dyslipidemia
Intervention:
17 Not yet recruiting Dolutegravir + Rilpivirine Switch Study (DORISS)
Conditions: HIV Infection;   HAART-treated;   Virologically Controlled
Interventions: Drug: Arm 1 (intervention);   Drug: Arm 2 (control)
18 Unknown † Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 2;   Drug: Placebo
19 Unknown † The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 3;   Drug: Fuzheng 1;   Drug: Placebo
20 Recruiting Therapeutic Approaches to HAART-Induced Lipodystrophy
Conditions: HIV Infections;   Lipodystrophy
Intervention: Drug: Metreleptin  (Leptin)
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years